文献速递系统性红斑狼疮其他结缔组织病血管炎

多组学分析揭示系统性红斑狼疮的内型及其与心血管和肾脏并发症的关联

Unveiling Endotypes in Systemic Lupus Erythematosus Through Multiomic Analysis: Insights Into Cardiovascular and Renal Complications.
PubMed 文献 · Arthritis Rheumatol · 2026-04-20

该研究对199例系统性红斑狼疮(SLE)患者血清进行蛋白质组学和靶向代谢组学分析,通过无监督聚类识别出两个分子亚群,cluster 1与损伤负担及狼疮肾炎、高血压、血脂异常、肥胖和炎症标志物异常率升高相关,多组学分析和外部队列验证了可重复性,提示分子内型可用于精准风险分层。

要点

  • 蛋白质组聚类识别出两个SLE分子亚群,cluster 1心血管风险特征更明显。
  • cluster 1的狼疮肾炎率是cluster 2的1.8倍,高血压3倍,血脂异常2倍,肥胖8倍。
  • 基于代谢物和临床变量的神经网络模型可区分聚类,AUC为0.77。

核心结论

  • 多组学分析可 delineate SLE 的分子内型,整合免疫、血管和代谢通路,与心血管风险和狼疮肾炎相关,支持其用于精准风险分层的潜力。

研究设计与样本

  • 研究纳入199例SLE患者血清,进行基于邻近延伸分析的蛋白质组学和靶向核磁共振代谢组学,对蛋白质组数据行无监督聚类,并进行多组学因子分析、逻辑回归和机器学习建模。
  • 验证队列包括伦敦大学学院SLE队列(部分使用扩展Olink Reveal panel和非靶向代谢组学),以及体外(人脐静脉内皮细胞和HK2细胞)和离体(大鼠肾脏)模型暴露于患者血清。

主要发现

  • 蛋白质组聚类识别出两个分子亚群(cluster 1和cluster 2),与cluster 2相比,cluster 1显示损伤负担和狼疮肾炎率增加1.8倍、高血压3倍、血脂异常2倍、肥胖8倍、C反应蛋白/红细胞沉降率异常4倍,符合心血管风险特征。
  • cluster 1中有47种炎症和器官损伤蛋白及多种代谢物升高。
  • 基于代谢物和临床变量的神经网络模型可区分聚类,曲线下面积(AUC)为0.77,柠檬酸盐和脂蛋白为关键特征。
  • 多组学分析和外部队列证实了可重复性,并富集于白细胞运输、内皮应激和肾炎相关通路。
  • 体外实验中,SLE患者血清与大鼠肾脏对照相比诱导NF-κB激活,支持促炎效应。

临床怎么用

  • 多组学分子内型可能有助于SLE患者心血管风险和狼疮肾炎的精准风险分层。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Systemic lupus erythematosus (SLE) shows clinical and molecular heterogeneity, and cardiovascular (CV) complications and lupus nephritis (LN) remain leading causes of morbidity and mortality. This study investigated whether omic profiling can reveal molecular endotypes linked to these outcomes. METHODS: Serum from 199 patients with SLE underwent proximity extension assay-based proteomics and targeted nuclear magnetic resonance metabolomics. Unsupervised clustering was performed on proteomic data, followed by integrative multiomic factor analysis, logistic regression, and machine learning models. Cohorts with SLE from the University College London, a subset with expanded Olink Reveal panel and untargeted metabolomics, and in vitro (human umbilical vein endothelial cell and HK2) and ex vivo (rat kidneys) models exposed to patient sera were used for validation and mechanistic exploration. RESULTS: Proteomic clustering identified two molecular subgroups (cluster 1 and cluster 2). Compared with cluster 2, cluster 1 showed damage burden and increased rates of LN (1.8-fold), hypertension (3-fold), dyslipidemia (2-fold), obesity (8-fold), and abnormal C-reactive protein/erythrocyte sedimentation rate (4-fold), consistent with CV risk. A total of 47 inflammatory and organ-damage proteins and multiple metabolites were increased in cluster 1. Neural network models based on metabolites and clinical variables discriminated clusters (area under the curve = 0.77), highlighting citrate and lipoproteins as key features. Multiomic analyses and external cohorts confirmed reproducibility and enrichment in pathways related to leukocyte trafficking, endothelial stress, and nephritis. In vitro, serum from patients with SLE induced NF-κB activation in rat kidneys compared with controls, supporting a proinflammatory effect. CONCLUSION: Multiomic profiling delineates molecular endotypes in SLE, integrating immune, vascular, and metabolic pathways associated with CV risk and LN, supporting their potential for precision risk stratification.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Cerdó T, Woodridge L, Corrales S, et al. Unveiling Endotypes in Systemic Lupus Erythematosus Through Multiomic Analysis: Insights Into Cardiovascular and Renal Complications. Arthritis Rheumatol. 2026. PMID: 41801022. doi:10.1002/art.70127

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。